The current market potential exists in the field of e-health and digital health devices as well as in treatments related to diabetes, obesity, other chronic diseases, and home-care equipment.
Due to trends in demographics, expenditure in these sectors is expected to keep rising.
Market entry of medical devices and in-vitro diagnostics is regulated through EU legislation. Thus, the same rules apply as in any other EU member state. Regarding the reimbursement of medical devices and in-vitro diagnostics, different rules apply for products used in inpatient care versus consumer medical devices and in-vitro diagnostics used in outpatient care.